Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

This client develops and produces treatment for life-threatening diseases around the world. In addition to antiviral and antiretroviral therapy used ...

The promising outlook for liquid biopsy diagnosis has sparked the interest of many in the biotech industry. The speed, ease, ...

A paper published this month proving that the use of RNA transposons can improve the CRISPR process has excited the ...

For several years, trends in modern medicine have been shifting towards promising treatments in cell and gene therapy. Backing these ...

On April 11, I attended the NC Tech Talk Live panel discussion on Cybersecurity Metrics in the very impressive WeWork ...

Clinical trials have long been viewed as complicated and high-volume endeavors, involving the widespread recruitment of patients, supply chain planning ...

The most innovative organizations have demonstrated their success stems from creative strategy paired with iterative and efficient execution. It’s all ...

Underlying all of the widespread uses of genetic testing—diagnostic testing, carrier testing, prenatal testing, consumer-oriented genetic testing, etc.—few issues loom ...

For pharmaceutical and biotechnology companies focusing on research and development, prioritizing data transparency and clinical study reporting (CSR) is a ...

The 11th annual Bio Supply Management Alliance (BSMA) conference brought together leaders from across the life sciences supply chain community ...